journal article·2025-01-08

Coagulation-Targeted TGF-β Signaling Pathway Inhibitor Nanomedicine for Inhibiting the Growth and Lung Metastasis of Breast Cancer

Yajun Xu, Jianlin Lv, Ya Liu, Jincheng Du, Chuwen Luo, Ying Wang, Linlin Liu, Kazuo Sakurai, Zhaohui Tang, Xuesi Chen

Nano Letters· Volume 25· Issue 1
Publisher page

Abstract

The transforming growth factor β (TGF-β) signaling pathway exerts a dual role in oncogenesis, acting as a suppressor in healthy and early stage neoplastic tissues while promoting malignancy and metastasis in advanced cancers. Tumor hemorrhage further exacerbates TGF-β-mediated metastasis by up-regulating its expression. Here, a coagulation-targeting peptide (A15)-decorated TGF-β inhibitor nanomedicine (A15-LY-NPs) was developed. The tumor colonization assays showed that the nanomedicine reduced 4T1-luc cell colonization in normal tissues. When combined with a vascular disrupting agent, A15-LY-NPs demonstrated three times greater drug accumulation in the tumor at 24 h compared to the control and showed a 93.7% tumor suppression rate in 4T1 tumors initiated at ∼500 mm 3, significantly attenuating metastatic spread to the lungs and liver. This study presents an innovative approach for the precise and efficient delivery of TGF-β inhibitors to tumors, offering the potential to augment the efficacy of cancer therapeutics.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: TGF-β signaling in diseases · S100 Proteins and Annexins · Cancer Cells and Metastasis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China

School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei 230026, China

Department of Radiation Oncology, China-Japan Union Hospital of Jilin University, Changchun 130033, Jilin, China

Department of Breast Surgery, The Second Hospital of Jilin University, Changchun 130041, China

Department of Chemistry and Biochemistry, The University of Kitakyushu, 1-1 Hibikino, Kitakyushu 808-0135, Japan

Funding

Key Technologies Research and Development Program · National Natural Science Foundation of China

References (40)

Show source-provided references
1. 10.3322/caac.2177710.3322/caac.21777 ↗
2. 10.1136/bmj-2022-07167410.1136/bmj-2022-071674 ↗
3. 10.1016/j.cell.2016.11.03710.1016/j.cell.2016.11.037 ↗
4. 10.1016/j.tcb.2020.07.00310.1016/j.tcb.2020.07.003 ↗
5. 10.1038/nature1703810.1038/nature17038 ↗
6. 10.1038/s41467-021-23466-510.1038/s41467-021-23466-5 ↗
7. 10.1038/s41556-024-01409-810.1038/s41556-024-01409-8 ↗
8. 10.1038/s41568-023-00656-510.1038/s41568-023-00656-5 ↗
9. 10.1016/j.trecan.2016.11.00810.1016/j.trecan.2016.11.008 ↗
10. 10.1038/s41568-021-00413-610.1038/s41568-021-00413-6 ↗
11. 10.1038/ng1001-11710.1038/ng1001-117 ↗
12. 10.1038/s41580-018-0007-010.1038/s41580-018-0007-0 ↗
13. 10.1161/CIRCULATIONAHA.122.06307510.1161/CIRCULATIONAHA.122.063075 ↗
14. 10.1126/scitranslmed.300692710.1126/scitranslmed.3006927 ↗
15. 10.1126/scisignal.aau854410.1126/scisignal.aau8544 ↗
16. 10.1038/s41467-023-39035-x10.1038/s41467-023-39035-x ↗
17. 10.1038/s41392-024-01764-w10.1038/s41392-024-01764-w ↗
18. 10.1038/s41416-021-01309-w10.1038/s41416-021-01309-w ↗
19. 10.1056/NEJM19990902341100610.1056/NEJM199909023411006 ↗
20. 10.1126/scitranslmed.aay486010.1126/scitranslmed.aay4860 ↗
21. 10.1016/j.biomaterials.2022.12173610.1016/j.biomaterials.2022.121736 ↗
22. 10.1002/cjoc.20220006510.1002/cjoc.202200065 ↗
23. 10.1002/adma.20200209410.1002/adma.202002094 ↗
24. 10.1002/adma.20231249310.1002/adma.202312493 ↗
25. 10.1038/s41392-020-00436-910.1038/s41392-020-00436-9 ↗
26. 10.1186/s40425-018-0356-410.1186/s40425-018-0356-4 ↗
27. 10.1186/s12885-023-11153-110.1186/s12885-023-11153-1 ↗
28. 10.1016/S1470-2045(22)00446-610.1016/S1470-2045(22)00446-6 ↗
29. 10.1158/1078-0432.CCR-14-138010.1158/1078-0432.CCR-14-1380 ↗
30. 10.1126/scitranslmed.aay845610.1126/scitranslmed.aay8456 ↗
31. 10.1021/acsnano.3c0029510.1021/acsnano.3c00295 ↗
32. 10.1016/j.actbio.2021.07.05110.1016/j.actbio.2021.07.051 ↗
33. 10.1016/j.actbio.2023.04.00110.1016/j.actbio.2023.04.001 ↗
34. 10.1161/01.CIR.0000134484.11052.4410.1161/01.CIR.0000134484.11052.44 ↗
35. 10.1038/nmat304910.1038/nmat3049 ↗
36. 10.1039/D3BM01858J10.1039/D3BM01858J ↗
37. 10.1093/nsr/nwad31010.1093/nsr/nwad310 ↗
38. 10.1016/j.actbio.2017.02.00110.1016/j.actbio.2017.02.001 ↗
39. 10.1002/smll.20150032410.1002/smll.201500324 ↗
40. 10.1038/sj.cr.729017910.1038/sj.cr.7290179 ↗